Nuclear Medicine research

Current Projects

• Establishing a normal range for breath test gastric emptying studies
• Gastric emptying in ICU patients using breath testing
• Renal function in transplant donors and recipients
• Development of ¹²³I agents for studying gastric emptying
• Gastric Emptying analysis software development for use with ¹²³I fatty acids
• Effect of strontium ranelate on bone density measurements
• Evaluation of lung scans using SPECT
• ^99mTc-Infliximab uptake in rheumatoid arthritis and inflammatory bowel disease

Publications

• DUNLOP R.  “The role of nuclear medicine in the diagnosis, treatment and monitoring of osteosarcoma - a case study”.  ANZ Nuclear Medicine 2007; 38(3): 2-3.  (Winner of the Radiology SA Rookie Poster Award – 2007 ANZSNM Conference)
• CHATTERTON BE and CROMPTON JL. “Autologous transplant of submandibular gland as a source of tears: Demonstration of function on Tc-99m pertechnetate scintigraphy”. Clin Nuc Med 2006; 31(1): 46-47.
• BELLON M. “Educating the regulators”. ANZ Nuclear Medicine 2006; 37(1): Page 9N.
• RUBINO V and CHATTERTON B. “A case report of lower limb pain in a renal transplant recipient taking tacrolimus”. ANZ Nuclear Medicine 2006; 37(1): 1-3.
• CHEW G. ”Renal Scintigraphy (Part 2)”. ANZ Nuclear Medicine 2006; 37(1): 17-21.
• CHATTERTON BE. “Nuclear Medicine and Thyroid Disease - Part II”. ANZ Nuclear Medicine 2005; 36(1): 30-32.
• SOJAN S and BARTHOLOMEUSZ D. “Cutaneous radiation necrosis as a complication of yttrium-90 synovectomy”. Hell J Nucl Med 2005; 8(1): 58-59.
• TEAGUE BD, MORRISON CP, COURT FG, CHIN VT, COSTELLO SP, KIRKWOOD ID and MADDERN GJ. “Role of FDG-PET in surgical management of patients with colorectal liver metastases”. ANZ J Surg, 2004; 74(8): 646-52.
• CHEUNG TK, TAM W, BARTHOLOMEUSZ D, HARLEY H and JOHNSON R.
  “Hepatic Hydropericardium”. J Gastroenterol Hepatol, 2004: 19(1): 109-12.
• COVENTRY BJ, CHATTERTON B, WHITEHEAD F, JAMES C and GILL PG. “Sentinel lymph node dissection and lymphatic mapping for local subcutaneous recurrence in melanoma treatment: longer-term follow-up results”. Ann Surg Oncol, 2004; 11(3 Suppl): 203S-7S.
• TAN KG, BARTHOLOMEUSZ FD and CHATTERTON BE. “Detection and follow-up of a biliary leak on Tc-99m DIDA SPECT-CT scans”. Clin Nucl Med, 2004; 29(10): 642-3.
• CHATTERTON BE, PENGLIS S, KOVACS JC, PRESNELL B and HUNT B. “Comparison of retention and distribution of two 99mTc-DTPA labelled vaginal dosage forms”. International J Pharmaceutics, 2004; 271/1-2 : 137-143.
• SHAW DW, WILLIAMS RBH, COOK IJ, WALLACE KL, WELTMAN MD, COLLINS PJ, MCKAY E, SMART R and SIMULA ME. “Oropharyngeal Scintigraphy: A reliable technique for the quantitative evaluation of oral-pharyngeal swallowing”. Dysphagia 2004; 19: 36-42.
• ROFFEY DM, LUSCOMBE ND, BYRNE NM, HILLS AP, BELLON M, TSOPELAS C, KIRKWOOD ID and WITTERT GA. “Use of [14C]-bicarbonate/urea to measure physical activity induced increases in total energy expenditure in free-living healthy males”. Asia Pac J Nutr 2005; 14(1): 83-90.
• YEOH EE, HOLLOWAY RH, FRASER RJ, BOTTEN RJ, DI MATTEO AC, MOORE J, SCHOEMAN MN, BARTHOLOMEUSZ FD “Anorectal dysfunction increases with time following radiation therapy for carcinoma of the prostate”. Am J Gastroenterol, 2004; 99(2): 361-9.
• BURNET RB and CHATTERTON BE. “Gastric emptying is slow in chronic fatigue syndrome”. BMC Gastroenterol, 2004; 4(1): 32.
• CHATTERTON BE. “Nuclear Medicine and Thyroid Disease - Part I”. ANZ Nuclear Medicine 2004; 35(4): 190-193.
• POP-BUSUI R, KIRKWOOD I, SCHMID H, MARINESCU V, SCHROEDER J, LARKIN D, YAMADA E, RAFFEL DM and STEVENS MJ. “Sympathetic dysfunction in Type 1 diabetes”. JACC 2004; 44(12): 2368-2374.
• BELLON M. “The urea breath test”. ANZ Nuclear Medicine, 2004; Vol 35 (2): 104-107.
• BURNET RB and CHATTERTON BE. “Gastric emptying is slow in chronic fatigue syndrome”. BMC Gastroenterology 2004, 4:32.
• HARDING JW and CHATTERTON BE. “Outcomes of patients referred for confirmation of brain death by 99mTc-exametazine scintigraphy”. Intensive Care Medicine 2003; 29(4): 539-543.
• CEHIC GA and BARTHOLOMEUSZ D. “Dual pathologic findings on heat-denatured Tc-99m erythrocyte scintigraphy with computed tomographic correlation”. Clin Nuc Med 2003; 28 (5): 400-401.
• BRUNDELL S, TUCKER K, CHATTERTON B and HEWETT P. “Influence of lavage timing on tumor cell burden during colonic resection”. Dis Colon Rectum 2003; 46(4): 460-466.
• BRUNDELL S, TSOPELAS C, CHATTERTON B, TOULOUMTZOGLOU J, BLEFARI C, HEWETT PJ. Effect of port composition on tumor cell adherence: an in vivo model. Dis Colon Rectum. 2003; 46:637-42.
• CHEW CG, BARTHOLOMEUSZ FDL, BELLON M and CHATTERTON BE. “Simultaneous 13C/14C dual isotope breath test measurement of gastric emptying of solid and liquid in normal subjects and patients: comparison with scintigraphy”. Nuclear Medicine Review 2003; 6(1): 29-33.
• GOULD AR, SHARP PJ, SMITH DR, STEGINK AJ, CHASE CJ, KOVACS JC, PENGLIS S, CHATTERTON BE and BUNN CL. “Increased permeability of psoriatic skin to the protein, plasm activator inhibitor 2”. Arch Dermatol Res, 2003; 295(6): 249-254.
• CHEW CG and SOTIROPOULOS P. “Uptake of Tc-99m pertechnetate by lactating breasts during a thyroid scan in a postpartum patient”. Clin Nuc Med, 2003; 28(5): 441-442.
• Assessment in renal transplantation, B. E. Chatterton. - in Nuclear Medicine in Clinical Diagnosis AM Peters (ed) 2003 Martin Dunitz (pub) London ISBN 1-89906-650-0 pp 239-251.
• Lymphoscintigraphy.. J. F. Thompson, R. Uren, B. J. Coventry & B. E. Chatterton.- In: Cutaneous Melanoma (C. M. Balch, A. N. Houghton, A. J. Sober & S. Soong, eds). Quality Medical Publishing, ISBN 1-57626-159-X, 2003 (4th edition).
• CHATTERTON BE, COVENTRY B, MENSFORTH D and COHEN P. “Hibernoma, intense uptake seen on Tc-99m tetrofosmin and FDG PET scanning”. Clin Nuc Med 2002; 27 (5): 369-370.
• SUTTON R, TSOPELAS C, CHATTERTON BE, COVENTRY B and KOLLIAS J. “Sentinel node biopsy and lymphoscintigraphy with a technetium 99m labelled blue dye in a rabbit model”. Surgery, 2002; 131(1): 44-49.
• BRUNDELL SM, TSOPELAS C, CHATTERTON B, TOULOUMTZOGLOU J and HEWETT PJ. “Experimental study of peritoneal blood flow and insufflation pressure during laparoscopy”. Br J Surg 2002; 89: 617-622.
• ANDERSON DL, BARTHOLOMEUSZ FDL, KIRKWOOD ID, CHATTERTON BE, SUMMERSIDES G, PENGLIS S, KUCHEL T, and SANSOM L. “Gastric emptying in the pig: the effect of concentration of inhaled isoflurane”. J Nuc Med 2002; 43: 968-971.
• SHAW DW, WILLIAMS RBH, COOK IJ, WALLACE KL, WELTMAN MD, COLLINS PJ, MCKAY E, SMART R and SIMULA ME. “Oropharyngeal scintigraphy: A reliable technique for the quantative evaluation of oral-pharyngeal swallowing. Submitted to Journal of Nuclear Medicine 2002.
• BRUNDELL SM, TUCKER K, CHATTERTON B and HEWETT PJ. “The effect of lavage on intraabdominal cell burden”. Surg Endosc 2002; 16(7): 1064-7.
• BRUNDELL SM, TUCKER K, TEXLER M, BROWN B, CHATTERTON B and HEWETT PJ. “Variables in the spread of tumor cells to trocars and port sites during operative laparoscopy”. Surg Endosc 2002; 16(10): 1413-9.
• VISVANATHAN R, LECAMWASAM D and CHATTERTON B. ‘Bang and it was gone!’ : an acute onset dementia? Clin Pract Rev 2002; 3(2): 71-73.
• SUTTON R, KOLLIAS J, PRASAD V, CHATTERTON B and GILL PG. “Same-day lymphoscintigraphy and sentinel node biopsy for early breast cancer [in process citation]”. ANZ J Surg 2002; 72(8): 542-6.
• BRUNDELL S, TUCKER K, CHATTERTON B and HEWETT PJ. “Experimental study of the material composition of laparoscopic ports on tumour cell adherence”. Br J Surg 2002; 89(7): 928-32.
• CHATTERTON BE, PENGLIS S, KOVACS JC, PRESNELL B and HUNT B. “Comparison of retention and distribution of two 99mTc-DTPA labelled vaginal dosage forms”. Submitted to the Journal of Nuclear Medicine 2002.
• VAN DER PLOEG GE, GUNN SM, WITHERS RT, MODRA AC, KEEVES JP and CHATTERTON BE. “Predicting the resting metabolic rate of young Australian males”. Eur J Clin Nutrit 2001; 55: 145-152.
• BARTHOLOMEUSZ FDL, BELLON MS, RAHMAN T, MOHD SHAH AS, ABDULLAH A and CHATTERTON BE. “Simplified 13C urea vs 14C urea breath tests : comparison of quantitative results accuracy and patient preference”. Hellenic J. Nuc. Med, 2001; 4(2): 100-103.
• BURNET RB, CHATTERTON BE, GAFFNEY RD and SCROOP G. “Total body potassium: variations in clinical subgroups of chronic fatigue syndrome”. Hellenic J. Nuc. Med, 2001; 4(2): 104-107.
• CHATTERTON BE. “Pleural activity in a patient with lumbo-pleural shunt following intrathecal injection of Tc-99m DTPA”. Clin Nucl Med 2000; 25(4): 305.
• CHEW CG, CHATTERTON BE, BARTHOLOMEUSZ, FDL. Reduced hepatic uptake of 99mTc stannous colloid labelled leucocytes in a patient with congenital hepatic fibrosis and alcoholic liver disease”. Clin Nuc Med, 2000; 25(9): 743-746.
• COOK IJ, FURUKAWA Y, PANAGOPOULOS V, COLLINS PJ and DENT J. “Relationships between spatial patterns of colonic pressure and individual movements of content”. Am J Physiol Gastrointest Liver Physiol, 2000; 278: G329-G341.
• WARREN JD, CHATTERTON B and THOMPSON PD. “A SPECT study of the anatomy of transient global amnesia”. Journal of Clinical Neuroscience 2000; 7(1): 57-59.
• KOLLIAS J, GILL PG, COVENTRY BJ, MALYCHA P, CHATTERTON B and FARSHID G. “Clinical and histological factors associated with sentinel node identification in breast cancer”. Aust N Z J Surg 2000; 70 (7): 485-9.
• KOLLIAS J, GILL PG, CHATTERTON B, RAYMOND W and COLLINS P. “Sentinel node biopsy in breast cancer: recommendations for surgeons, pathologists, nuclear physicians and radiologists in Australia and New Zealand”. Aust N Z J Surg 2000; 70 (2): 132-6.
• SHAPIRO B, RUFINI V, JARWAN A, GEATTI O, KEARFOTT KJ, FIG LM, KIRKWOOD ID and GROSS MD. “Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer”. Seminars in Nuc. Med 2000; XXX (2): 115-132.
• CHEW G, BARTHOLOMEUSZ D and CHATTERTON B. “Reduced hepatic uptake of tracer on a stannous colloid labelled leukocyte scan in a patient with congenital hepatic fibrosis and alcoholic liver disease”. Clin Nuc Med, 2000; 25(9): 743-746.
• ID KIRKWOOD, DI QUINT, A HAIG and RL WAHL,
  Painful schmorl’s node: another cause of vertebral photopenia on Indium-111-labelled leukocyte scintigraphy.
  Clin. Nuc. Med, 1999; 24(3): 206-208.
• D. BARTHOLOMEUSZ, BE CHATTERTON, JC BELLEN, R. GAFFNEY and A. HUNTER,
  Segmental colonic transit after oral 67Ga-citrate in healthy subjects and those with chronic idiopathic constipation. J Nucl Med, 1999; 40(2): 277-282.
• CHATTERTON BE,
  Pleural activity in a patient with lumbo-pleural shunt following intrathecal injection of Tc-99m DTPA. Clin. Nuc. Med 1999;
• BARTHOLOMEUSZ FDL, CHATTERTON BE, BELLEN JC, GAFFNEY R and HUNTER A,
  Segmental colonic transit after oral 67Ga-Citrate in healthy subjects and those with chronic idiopathic constipation. J. Nucl. Med, 1999; 277-282.
• KWIATEK MA, JONES KL, BURCH WM, HOROWITZ M and FDL BARTHOLOMEUSZ,
  Use of technegas as a radiopharmaceutical for the measurement of gastric emptying. Eur. J. Nuc. Med, 1999; 26: 903-906.
• KOLLIAS J, GILL PG, CHATTERTON BE, HALL VE, BOCHNER MA, COVENTRY BJ and FARSHID G,
  Reliability of sentinel node status in predicting axillary lymph node involvement in breast cancer. MJA 1999; 171 (9): 461-465.
• KIRKWOOD ID, FREY K, KOROBKIN MT. “Bilateral obstructive uropathy and anuria from a single ureteric calculus”. Clinical Nuclear Medicine 1998; 23 (10): 704-6.
• COVENTRY BJ, WATSON DI, TUCKER K, CHATTERTON B AND SUPPIAH R. “Intraoperative scintigraphic localisation and laparoscopic excision of accessory splenic tissue”. J. Surg, Endosc, 1998; 12: 159-161.
  

Presentations

• BARTHOLOMEUSZ D, BOTTEN R, DI MATTEO A, FRASER R, HOLLOWAY R and YEOH E.  “67Ga colonic transit scans reveal long term changes in distal colonic transit associated with anorectal symptoms and dysfunction following radiotherapy (RT) for prostate cancer CaP).  Proceedings of the ANZSNM 37th Annual Scientific Meeting Adelaide, 2007; Page 41.
• KEPKA V.  “CSF Shunt Study – A Case Study”.  Proceedings of the ANZSNM 37th Annual Scientific Meeting Adelaide, 2007; Page 60.  DUNLOP R.  “The role of Nuclear Medicine in the Diagnosis, Treatment and Monitoring of Osteosarcoma – A Case Study”.  Proceedings of the ANZSNM 37th Annual Scientific Meeting Adelaide, 2007; Page 56. 
• BROWN MP, DARBY JM, PENSA K, MANAVIS J, SMYTH D, TSOPELAS C and AL-EJEH F.  “Investigation of a novel cell-death ligand to evaluate tumour chemoresponsiveness”.  Proceedings of the ANZSNM 37th Annual Scientific Meeting Adelaide, 2007; Pages 18-19.
• TSOPELAS C, ADAM B, LIEBREGTS T, HOLTMANN G and BARTHOLOMEUSZ FDL.  “Scintigraphic evaluation of an animal model of colonic transit using 99mTc-rhenium sulphide colloid in live rats”.  Proceedings of the ANZSNM 37th Annual Scientific Meeting Adelaide, 2007; Pages 49-50.
• PUOPOLO M, LIAU N and BARTHOLOMEUSZ FD.  “Pilonidal sinus identified on a PET/CT scan”.  Proceedings of the ANZSNM 37th Annual Scientific Meeting Adelaide, 2007; Page 62. 
• LITTLE TJ, RUSSO A, HOROWITZ M, MEYER JH, SMYTH DR, JONES KL, BELLON M and FEINLE-BISSET C.  “The effects of free fatty acids on gastric emptying, plasma cholecystokinin, appetite and energy intake are more potent than those of triglycerides”.  Proceedings of the ANZSNM 37th Annual Scientific Meeting Adelaide, 2007; Page 49.
• TRINH T. “Gated blood pool scanning: Planar versus S.P.E.C.T”. Proceedings of the ANZSNM 37th Annual Scientific Meeting Adelaide, 2007; Page 44.
• HUGHES K. “Abscess or tumour?” Proceedings of the ANZSNM 37th Annual Scientific Meeting Adelaide, 2007; Page 55.
• JAIN A, RUBINO V, KITCHENER M, SEBBEN R, FITRIDGE R, LIAU N and UNGER SA. “A comparison of radionuclide and MRI scans in the evaluation of osteomyelitis in the diabetic foot”. Proceedings of the ANZSNM 37th Annual Scientific Meeting Adelaide, 2007; Page 25.
• ADAM B, LIEBREGTS T, IYNGKARAN G, BARTHOLOMEUSZ D, BELLON M, BOLWELL J and HOLTMANN G. “A gastric emptying stress test helps diagnose functional dyspepsia”. Proceedings of the 36th ANZSNM Annual Scientific Meeting, Perth 2006; Page 15.

• BARTHOLOMEUSZ D. “99mTc infliximab scans measure disease activity in inflammatory bowel disease (IBD) but leukocyte scans are better”. Proceedings of the 36th ANZSNM Annual Scientific Meeting, Perth 2006; Page 15-16.
• IYNGKARAN G, TSOPELAS C, SIVANESAN S, HETZEL D and BARTHOLOMEUSZ D. “99mTc-infliximab scans measure disease extent and activity in inflammatory bowel disease (IBD)”. Submitted to DDW 2006.
• ADAM B, TSOPELAS C, LIEBREGTS T, BARTHOLOMEUSZ D and HOLTMANN G. “Genetic differences determine inflammatory response and development of visceral hyperalgesia in a rat model”. Submitted to DDW 2006.
• ADAM B, LIEBREGTS T, IYNGKARAN G, BARTHOLOMEUSZ D, BELLON M, BOLWELL J and HOLTMANN G. “Meal related symptoms and gastric motor function”. Submitted to DDW 2006.
• NGUYEN N, BELLON M, BRYANT L, BURGSTADT C, BARTHOLOMEUSZ D, CHAPMAN M, FRASER R, BUTLER R, DAVIDSON G and HOLLOWAY R. “The role of 13C octanoic acid breath testing in the assessment of gastric emptying in critically ill patients”. Submitted to DDW 2006.
• COLLINS P. “Transport of nuclear medicine radionuclides between institutions – a user’s guide”. Proceedings of the 35th ANZSNM Annual Scientific Meeting, Melbourne 30th April – 2nd May 2005
• PUOPOLO M. (Radpharm Case Presentation). “CSF shunt function case study”. Proceedings of the 35th ANZSNM Annual Scientific Meeting, Melbourne 30th April – 2nd May 2005
• RUBINO V, UNGER S, BARNDEN L and RUFFIN R. “Comparison of single photon emission tomography to multi-slice helical computed tomography in the diagnosis of pulmonary embolism in patients with indeterminate ventilation perfusion scintigraphy”. Proceedings of the 35th ANZSNM Annual Scientific Meeting, Melbourne 30th April – 2nd May 2005
• MAGGS J, COTTER A, BARTHOLOMEUSZ D and CHATTERTON B. “Congenital Hypothyroidism. The role of nuclear medicine in diagnosis: a case of lingual thyroid”. Proceedings of the 35th ANZSNM Annual Scientific Meeting, Melbourne 30th April – 2nd May 2005
• BARTHOLOMEUSZ D and SOJAN S. “Further communication on radionecrosis of the skin following Yttrium-90 synovectomy”. Hellenic Journal of Nuclear Medicine 2005.
• NGUYEN N, CHAPMAN M, BRYANT L, NG MP, BELLON M, FRASER R, BURGSTADT C, BARTHOLOMEUSZ D and CHATTERTON B. “Delayed gastric emptying in critically ill patients-are we there yet”. Winner Nimmo Prize, RAH Grand Round 2005.
• TRINH T, BARTHOLOMEUSZ D and TAN M. “Colovesical fistula following rectal adenocarcinoma detected on 18FDG PET imaging”. Proceedings of the 34th ANZSNM Conference 2004, ANZ Nuclear Medicine, Page 2.
• BARTHOLOMEUSZ FDL, TSOPELAS C, PENGLIS S, MILLER D, JILBERT A, CAI F and RISCHMUELLER M. “99mTc-infliximab detects inflammation: biodistribution studies in patients with rheumatoid arthritis”. Proceedings of the 34th ANZSNM Conference 2004, ANZ Nuclear Medicine, Page 36.
• BARTHOLOMEUSZ D, TAN M, HASSOLD K, ROEDIGER WEW and CHATTERTON B. “Focal bowel uptake in patients undergoing 18FDG PET scanning”. Proceedings of the 34th ANZSNM Conference 2004, ANZ Nuclear Medicine, Page 48.
• COLLINS PJ. “Gastric emptying revisited: A new analysis program written in IDL”. Proceedings of the 34th ANZSNM Conference 2004, ANZ Nuclear Medicine, Page 33.
• TAN KG, KOVACS JC, and CHATTERTON BE. “Comparison of blinded interpretation of myocardial perfusion SPECT with and without attenuation and scatter correction”. Proceedings of the 34th ANZSNM Conference 2004, ANZ Nuclear Medicine, Page 46.
• PUOPOLO M, TAN KG and TSOPELAS C. “Altered distribution of 99mTc-technegas in a lung scan - an interesting case study”. Proceedings of the 34th ANZSNM Conference 2004, ANZ Nuclear Medicine, Page 58.
• BARTHOLOMEUSZ D, BOTTEN R, DI MATTEO A, MCGOWAN R, GAFFNEY R, FRASER R and YEOH E. “67Ga scintigraphy shows altered colonic transit in patients post radiotherapy for prostatic cancer”. Proceedings of the 33rd ANZSNM Conference 2003, ANZ Nuclear Medicine, Pages 38-39.
• KOVACS JC, BARTHOLOMEUSZ FDL, NGUYEN N, ABU-SNEINEH A, SCHOEMAN M and ARENS M. “Radionuclide oesophageal clearance study in the monitoring of fibrin glue treatment of an oesophagopleural fistula”. Proceedings of the 33rd ANZSNM Conference 2003, ANZ Nuclear Medicine, Pages 39-40.
• COLLINS P, COVENTRY BJ, KOLLIAS J, BOCHNER M, RODGERS N, GILL PG and CHATTERTON B. “The radiation dose to surgeon and pathologist in lymphatic mapping and sentinel lymph node biopsy surgery”. Proceedings of the 33rd ANZSNM Conference 2003, ANZ Nuclear Medicine, Page 20.
• KOVACS JC, CHATTERTON BEC and HARDING JW. “Malignant thymoma presenting as mediastinal soft tissue uptake on a whole body bone scan”. Proceedings of the 33rd ANZSNM Conference 2003, ANZ Nuclear Medicine, Page 45.
• HUGHES K. “Nuclear medicine in staging and assessing treatment response in a patient with neuroblastoma”. Proceedings of the 33rd ANZSNM Conference 2003, ANZ Nuclear Medicine, Page 9.
• BLEFARI C, BRUNDELL SM, TSOPELAS C, CHATTERTON B, TOULOUMTZOGLOU J and HEWETT PJ. “The effect of trocar composition on tumour cell adherence: an in vivo model. Aust NZ Soc Nucl Med J, 2003; 34(2): 87.
• CHATTERTON BE, PENGLIS S, KOVACS JC, PRESNELL B and HUNT B. “Assessment of the delivery retention and distribution of a mucoadhesive vaginal mousse formulation”. Proceedings 32nd ANZSNM Conference 2002; Page 37.
• BELLON MS, CHAPMAN M, BARTHOLOMEUSZ FDL, CREED S, RUSSO A and FRASER R. “14C Octanoic acid breath tests correlate with scintigraphy in the critically ill”. Proceedings 32nd ANZSNM Conference 2002; Page 18.
• HUGHES K, SCHULTZ CG and TRINH T. “The effect of varying the acquisition angle on processing and ejection fractions in gated blood pool studies”. Proceedings 32nd ANZSNM Conference 2002; Page 28.
• MARSHALL R, RISCHBIETH HM, JELBART JM, STRAYER J, CLARK J, DONOHOE S, CHATTERTON B and SCHULTZ C. “Conditioning of lower extremity muscle by low level neuromuscular electrical stimulation [(LE)NMES], has no influence upon either body composition or bone mineral density (BMD) after spinal cord injury (SCI)”. 1st JOINT SCIENTIFIC MEETING: IMSOP/ASIA, Vancouver May 3-6 2002.
• COVENTRY BJ, GILL PG and CHATTERTON B. “Lymphatic mapping and sentinel node biopsy for local subcutaneous recurrence in melanoma treatment – longer term follow-up results”. Proceedings of Sentinel Node 2002, Yokohama Japan Page154.
• COVENTRY BJ, COLLINS P, KOLLIAS J, BOCHNER M, RODGERS N, GILL PG and CHATTERTON B. “Radiation exposure to staff in lymphatic tracing and sentinel lymph node biopsy surgery”. Proceedings of Sentinel Node 2002, Yokohama
  Japan, Page195.
• CHAPMAN M, FRASER R, BARTHOLOMEUSZ F, CREED S, RUSSO A, JONES K, BELLON M, FINNIS M, CHATTERTON B and HOROWITZ M. “Delayed gastric emptying in the critically ill: correlation between scintigraphy and gastric aspirate volumes. Presented at Digestive diseases Week, San Francisco, May 2002.
• CEHIC GA, CHATTERTON BE and BARTHOLOMEUSZ FDL. “Serial ejection fraction studies in oncology patients”. Nucl Med Comm 2001; 22(8): 926.
• STANTON K, CEHIC G and KEEFE D. “A positive 111In-pentetreotide scan in a patient with a pancreatic polypeptide secreting tumour”. ANZSNM Annual Scientific Meeting Hobart 18th to 22nd May 2001.
• BRUNDELL SM, TSOPELAS C, CHATTERTON B, TOULOUMTZOGLOU J and HEWETT PJ. “Alterations in peritoneal blood flow due to insufflation: a mechanism implicated in the aetiology of port site metastases?” Proceedings of the 31st ANZSNM Conference 2001, ANZ Nuclear Medicine, Pages 82-83.
• KOVACS JC, CHATTERTON BE, KIRKWOOD ID and BLEFARI C. “Widespread abnormalities on a whole body iodine scan after therapeutic radioiodine due to clothing contamination”. Proceedings of the 31st ANZSNM Conference 2001, ANZ Nuclear Medicine, Pages 84-85.
• BRUNDELL SM, TSOPELAS C, BLEFARI C, CHATTERTON B, TOULOUMTZOGLOU J and HEWETT PJ. “The effect of trocar composition on tumour cell adherence: an in vivo model”. Proceedings of the 31st ANZSNM Conference 2001, ANZ Nuclear Medicine, Page 87.
• ANDERSON D, SUMMERSIDES G, BARTHOLOMEUSZ FDL, CHATTERTON BE, KIRKWOOD I and SANSOM L. “Enflurane delays gastric emptying in a pig model of liquid gastric emptying”. Nucl Med Comm 2001; 22(8): 925.
• BARTHOLOMEUSZ FDL, CREED S, BELLON M, YOUNG R and CHAPMAN M. “The measurement of gastro-tracheal aspiration in ventilated patients”. Proceedings of the 31st ANZSNM Conference 2001, ANZ Nuclear Medicine, Pages 86-87.
• RISCHBIETH A, BELLON M, and BARTHOLOMEUSZ FDL. “The pulmonary aspiration of oro-pharyngeal secretions in ventilated patients”. Nucl Med Comm 2001; 22(8): 925.
• BARTHOLOMEUSZ FDL and BELLON M. “14C urea breath test (CUBT) results in patients post eradication therapy, 5 year comparison”.
• MENSFORTH D, CHATTERTON BE, COVENTRY BJ & COHEN P. “Incidental finding of hibernoma on Tc-99m tetrofosmin cardiac scan”. Proceedings of the 31st ANZSNM Conference 2001, ANZ Nuclear Medicine, Page 87.
• BARTHOLOMEUSZ D, BOTTEN R, DI MATTEO AC, YEOH E, FRASER R. “Acute effects of radiation therapy for prostatic carcinoma on anorectal and colonic motor function”. To be presented at the Asian Pacific Digestive Week, Sydney, September 2001.
• ANDERSON DL, BELLON M, CHATTERTON B and MCGLONE JJ. “P.E.T studies of pig brain activity with biologically relevant and non-relevant odors”. HiRes (Small Animal Imaging meeting) Rockville, Sept 9-11 2001.
• BURNET RB and CHATTERTON B. “Gastric emptying in chronic fatigue syndrome”. 2nd Nuclear Medicine Meeting of Northern Greece, Thessaloniki, November 2-4 2001.
• CHATTERTON BE, THOMAS CM and SCHULTZ CG. “Dual energy x-ray absorptiometry (DEXA) in the assessment of liver iron in patients with beta thalassaemia major”. Nucl Med Comm 2000; 21(5): 488.
• BARTHOLOMEUSZ FDL, YEATES K and KRISHNAN S. “Lymphoscintigraphy in squamous cell cancer (SCC) of the head and neck”. Nucl Med Comm 2000; 21(5): 483.
• BELLON MS, BARTHOLOMEUSZ FDL and CHATTERTON BE. “The microdose rapid 14C urea breath test compares well with the original rapid 14 breath test”. Nucl Med Comm 2000; 21(5): 482-483.
• STANTON K. “ An assessment of gated myocardial thallium tomography and its clinical relevance”. ANZSNM 30th Annual Scientific Meeting, Adelaide, 20-24th May, 2000.
• YEATES K. “Ventriculo-pleural shunt patency study”. ANZSNM 30th Annual Scientific Meeting, Adelaide, 20-24th May, 2000.
• BLEFARI C. “Hepatic artery perfusion study: A technical review”. ANZSNM 30th Annual Scientific Meeting, Adelaide, 20-24th May, 2000..
• CZECHOWICZ KN, BRUNDELL S, PENGLIS S and CHATTERTON BE. “A novel technique for in-vitro labelling of colonic cancer cells”.ANZSNM 30th Annual Scientific Meeting, Adelaide, 20-24th May, 2000.
• CHEW CG, BARTHOLOMEUSZ FDL, BELLON M and CHATTERTON BE. “13C/14C dual isotope breath test measurement of gastric emptying in normal subjects and patients”. Nucl Med Comm 2000; 21(5): 488-489.
• CEHIC GA, ROWE CC, KITCHENER MI, CHATTERTON BE, OLVER IN, HORVATH N, LE P LANGLOIS S and RUSH J. “67Gallium citrate outperforms 99Tcm-sestamibi in evaluating lymphoma patients”. Nucl Med Comm 2000; 21(5): 498.
• J. KOVACS, B. E. CHATTERTON, J. MUECKE, S. PENGLIS,
  Radioimmunoscintigraphy in ocular melanoma. Nuclear Medicine Communications, 1999; 20: 361.

• K. M. STANTON,
  Incidental finding of a parasagittal meningioma on a parathyroid scan.
  Nuclear Medicine Communications, 1999; 20: 401.
• F. D. L. BARTHOLOMEUSZ, W. M. SUN, R. GAFFNEY, S. GANESANANTHAN,
  Gallium colonic transit study patterns in obstructive defaecation.
  Nuclear Medicine Communications, 1999; 20: 368.
• K. G. YEATES, F. D. L. BARTHOLOMEUSZ, S. KRISHNAN,
  The role of lymphoscintigraphy in squamous cell carcinoma of the tongue.
  Nuclear Medicine Communications, 1999; 20: 402.
• HEWETT PJ, TEXLER ML, ANDERSON D, KING G and CHATTERTON BE,
  In vivo real-time analysis of intraperitoneal radiolabeled tumour cell movement during laparoscopy. Dis Colon Rectum 1999; 42 (7): 868-75, discussion 875-6.
• T. Rahman, F.D.L. Bartholomeusz, M.S. Bellon, and B.E. Chatterton. A simplified 13c-urea breath test (13c-ubt) in the diagnosis of helicobacter pylori (HP) infection. ANZ J. Med, 1998; 28(3): 378.
• T. Rahman, K. M. Bannister. The value of post captopril renal scans in the presence of a small kidney. ANZ J. Med, 1998; 28(3): 378.
• D.L. Anderson, I.D. Kirkwood, B.E. Chatterton, F.D.L. Bartholomeusz and L.N. Sansom. The gastrointestinal emptying and transit of radiolabelled oral dosage forms in the pig. ANZ J. Med, 1998; 28(3): 377.
• D.L. Anderson, M.L. Texler, P.J. Hewitt, B.E. Chatterton and G.J. Maddern. 99mTc-sestamibi labelled tumour cell movement during laparoscopic surgery. ANZ J. Med, 1998; 28(3): 382.
• G. Cehic, B.E. Chatterton, F.D.L. Bartholomeusz, S. Le P Langlois, I. N. Olver, N. Horvath and C. Rowe. 99mTc-sestamibi whole body imaging-does it have a role in staging lymphoma patients? ANZ J. Med, 1998; 28(3): 382.